Categories: ConferencesEvents

Binaytara Foundation hosts ASCO Direct™ Highlights in Seattle

ASCO Direct™ Highlights Oncology conference held in Seattle to present and discuss the latest findings in cancer research and treatments

The Binaytara Foundation held the ASCO Direct™ Highlights: 2022 Official Annual Meeting Review in Seattle, WA, from June 17-19 to update oncology providers about the latest developments in the management of cancers. This CME-accredited oncology conference was designed to improve the care of cancer patients by educating clinicians involved in cancer care.

There were 197 attendees from fourteen different states at this cancer conference, from Hawaii to New Jersey. Faculty from local institutions and across the country were also in attendance, including well-known experts in the field of hematology and oncology. During the conference, there were twenty-two presentations from faculty and forty-five vendor companies represented.

Here are some highlights from evaluation survey respondents:

“The meeting was great.”

“Excellent conference. I plan to attend again.”

“Fantastic course with great speakers!”

“Wonderful conference – as usual.”

“Great conference – thanks to Dr. Bhatia and Dr. Grivas for leading and asking great questions. Speakers were knowledgeable and approachable for follow up questions. Good variety of topics and both ASCO updates as well as general information that is helpful to those of us in the community taking care of all tumor types. Thank you for a great educational event.”

An attendee of the Binaytara Foundation’s ASCO Direct™ Highlights conference on June 18-19, 2022.

“I am happy to help again in the future. Tara and Keegan are super nice,” added volunteer Rudy.

Photos from the conference taken by volunteer photographer Armin Isarian are below.

Attendees enjoying presentation
Attendees listen to the speaker
Speaker at conference

Future BTF conferences include the 2022 Cellular Therapy Conference in Salt Lake City, UT, Sept 9th-10th, the 2022 Precision Oncology Summit in Salt Lake City, UT, Oct 7th-8th, and the 2022 Seattle Multidisciplinary Thoracic Oncology Conference in Seattle, WA, Oct 22nd. For more information or to register for a conference, please visit education.binayfoundation.org.

About the Binaytara Foundation

The Binaytara Foundation is a global cancer non-profit dedicated to improving access to cancer care in the United States and abroad through education and innovative program models that break down barriers and advance best practices in hematology and oncology. Binaytara Foundation’s major projects include hematology and oncology conferences, and the establishment of a cancer hospital in Nepal. 

Staff Writer - The Cancer News

Recent Posts

ADRIATIC: durvalumab (D) as consolidation treatment (tx) for patients (pts) with limited-stage small-cell lung cancer (LS-SCLC)

By: Tiantian Zhang1, Yiqun Han2, Lei Deng3 1. Department of Internal Medicine, University of Central…

7 months ago

ASCO24 LAURA Trial Summary

By: Zhiting Tang1, Lei Deng21. Unity Hospital, Rochester Regional Health, Rochester, NY2. University of Washington/Fred…

7 months ago

FDA Approves Tovorafenib for Pediatric Low-Grade Glioma With BRAF Mutation

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Tisotumab Vedotin for Recurrent or Metastatic Cervical Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 29, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Lutetium Lu 177 Dotatate for SSTR-Positive Gastroenteropancreatic Neuroendocrine Tumors

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 23, 2024, the U.S. Food and Drug…

7 months ago

FDA Approves Alectinib for Adjuvant Treatment in Non-Small Cell Lung Cancer

By: Dr. Anish Shah Bronx-Lebanon Hospital; Bronx, NY On April 18, 2024, the U.S. Food and Drug…

7 months ago